Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,449-8,460 of 23,847
Drug study icon
CompletedNCT04533529

Seltorexant for depression

This study is completed in the United States, in Brazil, in Bulgaria, .... It is testing seltorexant for depression.

Multiple locations, including Anaheim
DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, Brazil, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT04532749

Seltorexant for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing seltorexant for depression.

Multiple locations, including Phoenix
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04513912

Seltorexant Compared to Quetiapine XR for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing Seltorexant Compared to Quetiapine XR for depression.

Multiple locations, including Birmingham
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT00182078

Sertraline to Prevent PTSD

This study is completed in the United States. It focuses on PTSD.

In Boston
PTSD, DepressionDrugFrom 6 Years to 20 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
PTSD, Depression
Other study type icon
CompletedNCT04946656

SPG Block for Opioid Withdrawal

This study is completed in the United States. It is testing SPG Block for Addiction.

In New York
AddictionOtherFrom 22 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Behavioral study icon
CompletedNCT05956340

Spoken Language in Mania

This study is completed in the United States. It is testing spoken Language for Bipolarity.

In Rochester
BipolarityBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
Behavioral study icon
CompletedNCT00156637

Strategies to Improve Schizophrenia Treatment

This study is completed in the United States. It focuses on schizophrenia.

Multiple locations, including Fayetteville
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Drug study icon
CompletedNCT01143090

Subjects Switched to Lurasidone for schizophrenia

This study is completed in the United States. It is testing subjects Switched to Lurasidone for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.